Company
ChinaBetta Pharmaceuticals Co., Ltd.-Site C, China – FDA Inspections
Inspection records and compliance data for Betta Pharmaceuticals Co., Ltd.-Site C. 2 FDA inspections on record, 1 Form 483, last inspected November 13, 2025.
Company Profile
This profile covers Betta Pharmaceuticals Co., Ltd.-Site C based in China.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 2
- Form 483s
- 1
- Warning letters
- 0
First inspected June 14, 2024. Last inspected November 13, 2025.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 13, 2025 | Not classified | Human Drugs | 1293932 |
| June 14, 2024 | Not classified | Human Drugs | 1243453 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Jiangxi Starry Pharmaceutical Co., Ltd
Zhejiang Supor Pharmaceuticals Co., Ltd.
Teva Pharmaceutical and Chemical (Hangzhou) Co. Ltd.
Zhongfu Pharmaceutical Co., Ltd.
Hebei Meishen Technology Co., Ltd.
Zhejiang Raybow Pharmaceutical Co., Ltd.
Shandong Topscience Bio-Tech Co., Ltd.
Hunan Er-Kang Pharmaceutical Co., Ltd.
Ruyuan Hec Pharm Co. Ltd.
Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd
Company Information
Name
Betta Pharmaceuticals Co., Ltd.-Site C
FEI Number
3015430059
Address
China
Country
China
ID: cad2d6c7-7a12-416d-a805-1e9cc5e6f42c